Stock RSPI RESPIRERX PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart RespireRx Pharmaceuticals Inc.

Equities

RSPI

US7612273059

Delayed OTC Markets
Other stock markets
 16:37:40 31/05/2024 BST 		5-day change 1st Jan Change
0.0031 USD -7.46% Intraday chart for RespireRx Pharmaceuticals Inc. +342.86% +244.44%
04-10 RespireRx Pharmaceuticals Inc. announced that it has received $0.1 million in funding CI
03-20 RespireRx Pharmaceuticals Inc. Reports Publication of Preclinical Research Results Demonstrating the Ability of CX1739, its Lead Clinical AMPAkine, to Improve Bladder Function After Spinal Cord Injury CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
RESPIRERX PHARMACEUTICALS INC. Stock RespireRx Pharmaceuticals Inc.
 2.74M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 114B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 105B
BIONTECH SE Stock BioNTech SE
 23.83B -
ARGENX SE Stock argenx SE
 21.73B -
GENMAB A/S Stock Genmab A/S
 18.1B
  1. Stock Market
  2. Equities
  3. RSPI Stock
  4. Charts RespireRx Pharmaceuticals Inc.
  5. Sector Chart